ibuprofen and Overweight

ibuprofen has been researched along with Overweight in 3 studies

Midol: combination of cinnamedrine, phenacetin, aspirin & caffeine

Overweight: A status with BODY WEIGHT that is above certain standards. In the scale of BODY MASS INDEX, overweight is defined as having a BMI of 25.0-29.9 kg/m2. Overweight may or may not be due to increases in body fat (ADIPOSE TISSUE), hence overweight does not equal over fat.

Research

Studies (3)

Authors

Clinical Trials (1)

Trial Overview

Trial Outcomes

Change From Baseline in 20-meter Walk

(NCT01535001)
Timeframe: Primary: 12months.

Change From Baseline in KOOS4 (Knee Injury and Osteoarthritis Outcome Score)

"The average score for four of the five KOOS subscales, covering pain, symptoms, difficulties in functions of daily living, and quality of life (KOOS4), with scores ranging from 0 (worst) to 100 (best).~Between group comparisons of treatment effect (change in KOOS4 from baseline to 1 year follow-up) will be dependent on data distribution. We expect the change to be normally distributed and analysis will be made using a mixed model ANOVA with subject being a random factor and visit (baseline, 3, 6 and 12 months), treatment arm (TKA + MEDIC, MEDIC) and site (Frederikshavn, Farsoe) being fixed factors. Baseline KOOS4 will be a covariate. Furthermore interactions between the fixed factors will be included in the model. P-values and 95% CI will be presented to assess superiority." (NCT01535001)
Timeframe: Primary: 12months.

Change From Baseline in Time From the Timed Up and Go

(NCT01535001)
Timeframe: Primary: 12 months.

Number of Serious Adverse Events Reported at Index Knee

Adverse events (AE) and seriously adverse events (SAE) will be registered in three ways and divided into index knee or sites other than index knee. The project physiotherapist will record any adverse events that the participant experiences or tells them about. For the participants allocated to, or crossing over to, TKA, a project worker will look through hospital records to register if any pre-defined perioperative and postoperative adverse events occurred. At all follow-ups, the assessor will use open-probe questioning to assess adverse events in all participants. (NCT01535001)
Timeframe: Primary: 12months.

Weight Change in kg From Baseline

Weight change in kg measured without shoes at the same time of day and on the same scale (NCT01535001)
Timeframe: Primary: 12months.

Change From Baseline in EQ-5D

"Between groups comparisons of the change from baseline to the 1 year follow-up in all secondary endpoint will be handled similar to the primary endpoint. See statistical analysis plan for further description (available under Links).~Range of EQ-5D Descriptive Index is -0.59 to 1.00 (worst to best), while the EQ VAS goes from 0 to 100 (worst to best)." (NCT01535001)
Timeframe: Primary: 12months.

Change in the Five KOOS Subscale Scores From Baseline

Range of all subscales are 0 to 100 (worst to best). (NCT01535001)
Timeframe: Primary: 12 months.

Proportion of Users of Pain Medication

With possible answers being yes and no (NCT01535001)
Timeframe: Baseline and 12months.

Reviews

1 review available for ibuprofen and Overweight

Trials

1 trial available for ibuprofen and Overweight

Other Studies

1 other study available for ibuprofen and Overweight